IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN COLOMBIA

被引：0
|
作者：
Lopez-Cabra, C. [1 ]
Rodriguez, A. D. [2 ]
Mayorga, Mogollon W. [2 ]
Zuluaga, J. R. [3 ]
Patino, A. [1 ]
Herran, S. E. [3 ]
Marrugo, R. [3 ]
机构：
[1] Bayer, Bogota, Cun, Colombia
[2] Numeris, Bogota, Colombia
[3] Bayer, Bogota, Colombia
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE425
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [11] Finerenone and Kidney Outcomes in Patients with CKD and T2D: Results from FIDELITY
    Bakris, George L.
    Ruilope, Luis M.
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Fried, Linda F.
    Roy-Chaudhury, Prabir
    Sarafidis, Pantelis
    Ahlers, Christiane
    Joseph, Amer
    Brinker, Meike D.
    Lawatscheck, Robert
    Agarwal, Rajiv
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B6 - B6
  • [12] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Makembi, Arriel B.
    Mohamadou, Inna
    Galichon, Pierre
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [13] A Prediction Model on Incident End-Stage Kidney Disease (ESKD) among Individuals with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)
    Lin, Yilu
    Shao, Hui
    Anderson, Amanda H.
    Fonseca, Vivian
    Batuman, Vecihi
    Shi, Lizheng
    DIABETES, 2022, 71
  • [14] RESOURCE AND COST BURDEN OF CHRONIC KIDNEY DISEASE (CKD) STAGE 3-5 NOT ON DIALYSIS (ND) IN THE UNITED KINGDOM (UK): TYPE 2 DIABETES (T2D) AND WITHOUT DIABETES
    Marx, Steven
    Petrilla, Allison
    Filipovic, Ivana
    Lee, Won Chan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 395 - 395
  • [15] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Bakris, George L.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Joseph, Amer
    Filippatos, Gerasimos
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23): : 2219 - 2229
  • [16] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes Reply
    Bakris, George L.
    Agarwal, Rajiv
    Filippatos, Gerasimos
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [17] Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
    Fu, Edouard L.
    Kutz, Alexander
    Desai, Rishi J.
    KIDNEY INTERNATIONAL, 2023, 103 (01) : 30 - 33
  • [18] Finerenone in patients with chronic kidney disease and type 2 diabetes mellitus
    Wanner, C.
    Nitschmann, S.
    INTERNIST, 2021, 62 (05): : 577 - 580
  • [19] BURDEN OF CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES USING THE STANDARD OF CARE IN COLOMBIA
    Mayorga, W.
    Lopez, D. S.
    Alvarado, A.
    Marrugo, R.
    Zuluaga, J. R.
    Patino, A.
    Herran, S. E.
    Lopez, C.
    VALUE IN HEALTH, 2022, 25 (07) : S376 - S376
  • [20] ECONOMIC BURDEN AMONG CHRONIC KIDNEY DISEASE (CKD) PATIENTS WITH AND WITHOUT TYPE 2 DIABETES (T2D) IN A COMMERCIALLY INSURED/MEDICARE ADVANTAGE (MA) POPULATION IN THE UNITED STATES (US)
    Chung, H.
    Thomas, N.
    Willey, V
    Kong, S. X.
    Singh, R.
    Farej, R.
    Williamson, T.
    VALUE IN HEALTH, 2022, 25 (07) : S381 - S381
12345